Source / episode info
- **Episode:**432
- **Title:**Divine Intervention Episode 432: Pharmacology Blitz
- **Published:**2022-12-29
- Source:Episode page
One-liner
This episode provides a rapid-fire review of high-yield pharmacology, covering the mechanisms and clinical pitfalls associated with vasodilators (nitrates), lipid-lowering agents (statins, fibrates, niacin, bile acid resins), antibiotics (vancomycin), metabolic drugs (metformin), and acute pancreatitis management.
High-yield summary
- Nitrates: Potent vasodilators acting via NO release and the cGMP pathway; they are contraindicated in patients with suspected Right Coronary Artery (RCA) infarcts because they reduce preload, which is critical for right ventricular filling.
- Statins: Inhibit HMG-CoA reductase, leading to decreased intracellular cholesterol synthesis in hepatocytes, which subsequently upregulates LDL receptors on the hepatocyte surface and increases systemic LDL clearance.
- Metformin (Biguanide): Inhibits hepatic gluconeogenesis; it improves insulin sensitivity by activating AMPK and promoting non-insulin dependent glucose utilization, but is contraindicated in conditions of poor tissue perfusion (e.g., shock) or acute kidney injury due to the risk of lactic acidosis.
- Lipid Agents: Niacin is best for raising HDL; Fibrates are best for lowering triglycerides; Bile acid binding resins prevent enterohepatic recirculation and lower cholesterol by increasing bile acid excretion.
- Vancomycin: A glycopeptide antibiotic that inhibits cell wall synthesis by binding to the D-Ala-D-Ala terminus of peptidoglycan precursors, preventing transpeptidases from cross-linking. Resistance occurs via modification to D-Ala-D-Lac (VRE).
Learning objectives
- Describe the mechanism of action and clinical contraindications for nitrates in acute coronary syndromes.
- Differentiate between various lipid-lowering agents based on their primary target (e.g., HDL vs. Triglycerides).
- Explain the metabolic pathway by which metformin lowers glucose levels and identify its key contraindications.
- Recognize the mechanism of action and resistance pathways associated with vancomycin.
- Correlate clinical presentations (e.g., severe hypertriglyceridemia, shock) with specific drug toxicities or diagnoses.
Board exam buzzwords